NCT01372501

Study of Obese Subjects Previously Implanted With the EndoBarrier Gastrointestinal Liner

A Pilot Trial of Obese Subjects Previously Implanted With the EndoBarrier Gastrointestinal Liner

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 19 (actual)
• Sponsor: Morphic Medical Inc. · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether the GI Endobarrier Liner can be reimplanted.

Detailed description

Patients with obesity are at significantly greater risk of developing significant co-morbid complications, and are associated with an increased risk in all-cause mortality. The GI Endobarrier Liner represents a viable alternative to other short-term weight loss methods. It is a minimally invasive endoscopic procedure, which may allow patients to recover faster with less morbidity and mortality. This study is investigating whether the the GI Endobarrier Liner can be reimplanted.

Conditions

• Obesity

Interventions

Type	Name	Description
DEVICE	Endobarrier Liner	Medical device placed endoscopically in the duodenum

Timeline

• Start date: 2010-09-01
• Primary completion: 2011-11-01
• Completion: 2012-09-01
• First posted: 2011-06-14
• Last updated: 2017-02-15
• Results posted: 2016-03-11

Locations

1 site across 1 country: Chile